Strengthening Healthcare and Investment Cooperation in Uganda
Exon Genetic & Biotechnology has maintained an active interest in Uganda as part of its wider African healthcare and investment strategy.
In a February 2020 report, the company described a Uganda business trip organized by BEYLER GROUP in which companies from Türkiye participated. The delegation was received through protocol facilitated by Uganda’s Ministry of Foreign Affairs and subsequently met President Yoweri Museveni under the leadership of CEO Dr. Hulusi Söğütlü.
The visit provided an opportunity to present proposed projects for Uganda and discuss ways of strengthening cooperation between Türkiye and Uganda.
Presenting Projects for Uganda
According to Exon’s official report, the delegation explained its proposed projects for Uganda to President Museveni in detail.
The discussions also included steps that could be taken to strengthen relations between Türkiye and Uganda.
For a company operating in healthcare and biotechnology, such engagement provides an important platform for communicating its investment vision and understanding the environment in which future projects could be developed.
Building International Healthcare Partnerships
Healthcare development often requires cooperation between government institutions, technology companies, medical suppliers, investors and professional organizations.
Exon Genetic & Biotechnology’s business activities include manufacturing laboratory diagnostic products, supplying medical equipment and consumables, and providing healthcare consultancy services.
The company states that it manufactures PCR test kits, rapid tests, biochemistry diagnostic tests, CBC tests, immunoassays and BTI products, while also providing healthcare consultancy and turnkey healthcare project services.
Helpful Advice
Quality Assurance
Reliable Experts
Supporting Turkey-Uganda Cooperation
The company’s 2020 report also highlighted the importance of maintaining and developing relations between Türkiye and Uganda.
According to Exon, President Museveni expressed appreciation to Dr. Hulusi Söğütlü for efforts associated with the organization and the Turkish Parliament Committee’s official visit to Uganda. The President also expressed satisfaction regarding the delegation’s visit and emphasized the importance of continued efforts to maintain relations.
The engagement therefore connected healthcare and investment interests with broader international cooperation.
Dr. Hulusi Söğütlü, CEO, BEYLER GROUP
“Uganda is an important partner for Türkiye in East Africa. We believe that strong relationships, meaningful investment and cooperation between our countries can create lasting opportunities for both sides. BEYLER GROUP remains committed to contributing to this shared vision through responsible investment and long-term partnerships.”
Uganda as a Strategic Market
Uganda has an important position within Exon Genetic & Biotechnology’s regional strategy.
The company states that its priority market is East Africa, with plans to expand its reach throughout Africa. Its Uganda operations include the production and supply of laboratory diagnostic products and other healthcare solutions.
The company also lists several Ugandan institutions among the authorities and organizations associated with the validation and registration of its products and operations.
A Foundation for Long-Term Engagement
The 2020 visit reflected the value Exon places on institutional engagement.
For biotechnology and healthcare organizations, long-term success requires more than product development. It also depends on regulatory understanding, professional partnerships, technical capabilities and engagement with the healthcare environment.
By meeting government leaders and participating in international business delegations, Exon and BEYLER GROUP have sought to strengthen their understanding of regional opportunities and establish relationships that can support future activities.
Conclusion
The Uganda business delegation reported in February 2020 represented an important stage in Exon Genetic & Biotechnology and BEYLER GROUP’s engagement with Uganda.
The discussions focused on proposed projects, investment opportunities and strengthening Turkey-Uganda relations.
Exon continues to operate in laboratory diagnostics, medical equipment, consumables and healthcare consultancy, with Uganda serving as an important part of its East African presence.
Work With Exon Genetic & Biotechnology
Whether you require laboratory diagnostic products, medical equipment, consumables or healthcare consultancy, contact Exon Genetic & Biotechnology to explore available solutions.
